Cipla buys stake in biosimilars market

According to FierceBiopharma, Indian drug company Cipla has purchased major stakes in Asian biotechs that have biosimilars in the pipeline. Their main goal is to create biosimilars of current biologics that are extremely expensive, Roche's Avastin, Herceptin and Enbrel. Read the full article here.

Share this article with your social network, just click below to share now!

Share |